Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumabAtsushi Mitsuhashi(Tokushima University), Yasuhiko Nishioka(Tokushima University)Nature CommunicationsDecember 4, 201510.1038/ncomms9792Cited by 78SaveCiteExport RISWatch citationsRelated PapersProgrammed death (PD)‐1/PD‐ligand 1 blockade mediates antiangiogenic effects by tumor‐derived CXCL10/11 as a potential predictive biomarker|Cancer Science|2021|16Development, validation, and comparison of gene analysis methods for detecting <i>EGFR</i> mutation from non-small cell lung cancer patients-derived circulating free DNA|Oncotarget|2019|6